The ICON Study: Outcomes After FMT for Patients With IBD and CDI

NCT03106844 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases
Clostridium Difficile Infection

Interventions

DRUG: Fecal Microbiota Transplantation

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]
[object Object]